AP
The startup is developing a novel analgesic drug that targets specific pain pathways to provide effective relief for patients experiencing chronic pain. By collaborating with academic institutions and healthcare professionals, the company aims to enhance patient outcomes and improve quality of life for those suffering from pain.
Updated 18 months ago
Funding
$8.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
KUFunding rounds are not available yet.
Founders
Product
Features
- The startup is developing a novel analgesic drug that targets specific pain pathways to provide effective relief for patients experiencing chronic pain. By collaborating with academic institutions and healthcare professionals, the company aims to enhance patient outcomes and improve quality of life for those suffering from pain.